You haven't searched anything yet.
ALX Oncology is a clinical-stage and patient-focused immuno-oncology company developing therapies that block the CD47 myeloid checkpoint pathway. Our lead candidate, evorpacept (ALX148), is a next generation CD47 blocking therapeutic that combines a high-affinity CD47 binding domain with an inactivated proprietary Fc domain. For more information about us, please visit www.alxoncology.com.
Reporting to the Senior Vice President of Clinical Development, the Senior/Executive Medical Director, Clinical Development will play a critical role in developing and executing the ongoing clinical trial strategies for our Oncology products.
Major Duties/Responsibilities:
Qualifications:
Salary: $240,000-$300,00 DOE
ALX Oncology is an equal opportunity employer. All applicants should be legally entitled to work for any employer in the US. Title and salary are commensurate with experience. Our compensation program includes competitive salary, equity participation and attractive bonus incentives.
Full Time
$255k-315k (estimate)
03/11/2024
05/10/2024
alxoncology.com
BURLINGAME, CA
25 - 50
2015
JAUME PONS
<$5M